Logiscreen

ANI Pharmaceuticals Inc

$71.17
Market Cap 1.62B
ROE 19.6%
Gross Margin 62.4%
Debt/Equity 1.0
Current Ratio 2.9
Revenue QoQ 25.9%
EPS QoQ 1.9%
F-Score 9

About

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
20.14
vs median 37.08
P/B
3.27
vs median 2.65
ROE
0.18
vs median 0.09

High quality company with strong fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics